Linda.Bunschoten

About Linda Bunschoten - Chief Marketing Officer

Linda has 25+ years of experience uncovering pain points and strategizing with companies in the healthcare industry in order to secure and retain more clients. Her chief thinking responsibilities include translating insight into strategy and ensure that all MarCom and Product Management activities contribute to our overall customer experience and meet our industry’s quality expectations.
Nov 2018

Dr Johann Proeve awarded 2018 MCC Champion

By |2018-12-06T08:52:03+00:00November 15, 2018|News|Comments Off on Dr Johann Proeve awarded 2018 MCC Champion

MCC Congratulates the 2018 Class of MCC Champions: "MCC bestows this special honor to those individuals who made significant contributions in 2018 in advancing the MCC mission to improve the efficiency, quality and effectiveness of clinical trials."

Oct 2018

Data Integration – A Valid Concern or a Convenient Excuse?

By |2018-10-15T15:10:53+00:00October 11, 2018|Blog, Conferences|Comments Off on Data Integration – A Valid Concern or a Convenient Excuse?

Conference season has started! Our first stop was the Global RBM Summit 2018 in London. Our CSO Dr Johann Proeve was invited to join the conversation as a speaker on the topic “Pragmatic Centralized Monitoring – How to get there?”. Johann shares his observations with us.

Jul 2018

DIA 2018 Global Annual Meeting: was this year’s theme the most dead-on yet?

By |2018-07-17T09:10:07+00:00July 16, 2018|Blog|Comments Off on DIA 2018 Global Annual Meeting: was this year’s theme the most dead-on yet?

The dramatic expansion of prescription drug deaths inspired this year's theme "driving insights to action". Insights that could be deployed through novel disruptive technologies such as Risk-based Quality Management (RBQM). Cyntegrity's Johann Proeve and Nimita Limaye were in Boston and share their observations with us.

Jun 2018

Medical Devices: Managing Risks Beyond Bullet Proof Clinical Evidence

By |2018-12-14T08:14:33+00:00June 6, 2018|Blog, Weekly RBM Feature|Comments Off on Medical Devices: Managing Risks Beyond Bullet Proof Clinical Evidence

The EU MDR is setting the stage for busy times ahead. The continuous need for clinical evidence, the increasing complexity of new medical devices, and the size and global nature of medical device trials introduce a greater potential for error. Learn how a risk-based approach enables MedTech manufacturers to better understand, manage and mitigate the growing uncertainties.

May 2018

Interview: “Oncology Trials are Different”

By |2018-10-02T05:41:24+00:00May 3, 2018|Blog, News|Comments Off on Interview: “Oncology Trials are Different”

Many risks in clinical trials seem therapy specific. To illustrate this, Dr Johann Proeve shares real life use cases he experienced during his years as Head of Global Data Management at Bayer HealthCare.

May 2018

“OncoRACT” – The First Therapy Specific RACT for Clinical Trials

By |2018-05-03T13:07:48+00:00May 1, 2018|Blog, News|Comments Off on “OncoRACT” – The First Therapy Specific RACT for Clinical Trials

Many risks in clinical trials are therapy specific. Because of that, the currently available tools addressing those risks are now becoming therapy specific as well. The first therapy focused risk library Oncology RACT (OncoRACT) recently got available.

Mar 2018

Blockchain in Clinical Trials – The Ultimate Data Notary

By |2018-03-14T14:00:11+00:00March 14, 2018|News, White Paper|Comments Off on Blockchain in Clinical Trials – The Ultimate Data Notary

Blockchain technology is the biggest achievement in cryptography of the past decade. Source Data Verification (SDV), which consumes about 20–30% of the clinical trial budget nowadays, will become redundant when blockchain technology disrupts the pharma industry.

Upcoming Events

  1. DIA Europe 2019

    February 5 - February 7

Register Today!

Get Free Test Access